CSF1 and COVID-19: For example, a longitudinal study demonstrated that while moderate COVID-19 cases had reduced plasma cytokine levels, severe COVID-19 cases maintained high levels of cytokines and chemokines such as Il-2, Il-16, CCL1, CCL2, and M-CSF, which were associated with monocytes and T cell recruitment and activation, and survival [7].